1,3,4-thiadiazole has been researched along with Koch's Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aminabhavi, TM; Joshi, SD; Koli, D; Kulkarni, MS; More, UA; Nadagouda, MN | 1 |
Alagawadi, KR; Alegaon, SG; Chaudhary, SM; Dadwe, DH; Shah, AS; Sonkusare, PV | 1 |
2 other study(ies) available for 1,3,4-thiadiazole and Koch's Disease
Article | Year |
---|---|
Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhA.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Design; Humans; Models, Molecular; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Quantitative Structure-Activity Relationship; Thiadiazoles; Tuberculosis | 2015 |
Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Topics: Acetates; Antitubercular Agents; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rhodanine; Thiadiazoles; Tuberculosis | 2012 |